DNA testing revolutionizes metastatic castration-resistant prostate cancer prognosis, improving patient outcomes with faster ...

Having the ctDNA test results back gave me a sense of relief that there was no one to blame, I couldn't be angry about it. 'The tablets help me keep my cancer in check, they are allowing me to ...

OneCell Diagnostics has secured $16 million in a Series A round as it aims to limit cancer recurrence using AI advancements ...

The test, made by Roche, the pharmaceutical firm, will be accurate for non-small cell cancers, which make up around four in five of the UK’s 34,000 yearly diagnoses. They are 100 per cent accurate ...

GRAIL (GRAL) announced that the first patient has been tested for eligibility with the investigational GRAIL Non-Small Cell Lung Cancer, or ...

Arnab Basu, MD, MPH, FACP, explains why sensitivity might be higher in urothelial cancer vs other genitourinary cancers.

PeCan-Seq enables sensitive, non-invasive ctDNA analysis for pediatric cancers, with high accuracy for hematologic ...

but Faces Challenges ctDNA tests have the potential to identify many cancer types but researchers must assess their efficacy across different racial/ethnic groups. MDedge News, April 21 ...

NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment ...

OneCell Diagnostics has secured $16 million in a Series A round as it aims to limit cancer recurrence using AI advancements ...